uploads///blood _

Johnson & Johnson Stock on March 29, 2018

By

Dec. 4 2020, Updated 10:53 a.m. ET

A look at Johnson & Johnson

As one of the largest pharmaceutical companies by revenue, Johnson & Johnson’s (JNJ) products are classified into three business segments: Pharmaceuticals, Consumer Healthcare, and Medical Devices. The chart below compares the one-week returns for Johnson & Johnson, its primary competitors, and the Health Care Select Sector SPDR ETF (XLV).

Article continues below advertisement

Johnson & Johnson’s stock performance 

With recent concerns over a trade war between the US and China, US indexes have seen significant volatility over the last few days. These concerns have also weakened most of the indexes.

Johnson & Johnson’s stock price has fallen ~2.9% in the last week. Its stock price rose ~0.2% to its closing price of $127.45 on March 28, 2018, compared to the previous closing price of $127.21 on March 27, 2018.

Johnson & Johnson’s stock price has fallen ~3.5% in the last month. Its stock price has risen ~1.4% in the last year. JNJ stock is trading 2.3% lower than its 30-day simple moving average on March 28, 2018.

Comparison with other stocks and the industry ETF 

The Health Care Select Sector SPDR ETF (XLV) reported a decrease of ~3.4% in the last week. The price for XLV rose ~0.5% to the closing price of ~$80.79 on March 28, 2018, compared to the previous close of $80.36 on March 27, 2018.

XLV’s price has increased ~8.6% in the last year. XLV holds 11.2% of its total investments in Johnson & Johnson (JNJ), 6.8% in Pfizer (PFE), 4.8% in AbbVie (ABBV), and 3.3% in Bristol-Myers Squibb (BMY).

Pfizer’s (PFE) stock price has fallen ~2.7% in the last week. Its closing price was $35.30 on March 28, 2018, an ~0.8% increase compared to the previous closing price of $35.01 on March 27, 2018.

AbbVie’s (ABBV) stock price has fallen ~16.2% in the last week. Its closing price was $94.27 on March 28, 2018, an ~2.4% increase compared to the previous close of $92.01 on March 27, 2018.

Bristol-Myers Squibb’s (BMY) stock price has fallen ~5.3% in the last week. Its closing price was $62.57 on March 28, 2018, an ~0.3% increase compared to the previous close of $62.41 on March 27, 2018.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.